TSE:EXE Extendicare (EXE) Stock Price, News & Analysis C$8.84 -0.04 (-0.45%) (As of 09/6/2024 05:28 PM ET) Add Compare Share Share Today's RangeC$8.77▼C$8.9550-Day RangeC$7.15▼C$8.9152-Week RangeC$5.75▼C$9.16Volume156,046 shsAverage Volume131,063 shsMarket CapitalizationC$737.87 millionP/E Ratio13.00Dividend Yield5.43%Price TargetC$9.17 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlines Get Extendicare alerts: Email Address Extendicare MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside3.7% UpsideC$9.17 Price TargetShort InterestN/ADividend StrengthModerateBased on Four FactorsSustainabilityN/ANews Sentiment0.59Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.55 out of 5 stars 1.3 Analyst's Opinion Consensus RatingExtendicare has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageExtendicare has only been the subject of 1 research reports in the past 90 days.Read more about Extendicare's stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for EXE. Previous Next 2.5 Dividend Strength Dividend LeadershipExtendicare is a leading dividend payer. It pays a dividend yield of 5.39%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthExtendicare does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Extendicare is 70.59%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about Extendicare's dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for EXE. Previous Next 2.0 News and Social Media Coverage News SentimentExtendicare has a news sentiment score of 0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Extendicare this week, compared to 1 article on an average week.MarketBeat FollowsOnly 1 people have added Extendicare to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Extendicare insiders have not sold or bought any company stock.Percentage Held by Insiders13.92% of the stock of Extendicare is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 19.12% of the stock of Extendicare is held by institutions.Read more about Extendicare's insider trading history. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Extendicare is 13.00, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 127.87.Price to Earnings Ratio vs. SectorThe P/E ratio of Extendicare is 13.00, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 115.64.Price to Book Value per Share RatioExtendicare has a P/B Ratio of 6.91. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Extendicare's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Paradigm PressKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move… Click here now and learn how to prepare. About Extendicare Stock (TSE:EXE)Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was incorporated in 1968 and is based in Markham, Canada.Read More EXE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EXE Stock News HeadlinesSeptember 5 at 3:07 AM | americanbankingnews.comExtendicare (TSE:EXE) Given New C$9.50 Price Target at TD SecuritiesAugust 22, 2024 | msn.comThis 5.8%-Yielding Dividend Stock is a Top Option for Safe IncomeSeptember 7, 2024 | Weiss Ratings (Ad)“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.August 19, 2024 | markets.businessinsider.comRBC Capital Remains a Hold on Extendicare (EXE)August 19, 2024 | msn.comAltius at 52-Week High on NewsAugust 16, 2024 | finance.yahoo.comExtendicare Second Quarter 2024 Earnings: EPS: CA$0.30 (vs CA$0.023 in 2Q 2023)August 14, 2024 | finance.yahoo.comIs Extendicare Inc. (TSE:EXE) Potentially Undervalued?July 19, 2024 | theglobeandmail.comClosing Bell: Extendicare Inc flat on Wednesday (EXE)September 7, 2024 | Weiss Ratings (Ad)“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.May 22, 2024 | msn.comDividend Investors Can Earn $500 Every Month or More With the Right Stock Offering a 6% YieldMay 6, 2024 | finance.yahoo.comThose who invested in Extendicare (TSE:EXE) a year ago are up 18%April 30, 2024 | finance.yahoo.comAlayaCare Selected by ParaMed as Technology Platform to Power Home Health Care Across CanadaApril 9, 2024 | theglobeandmail.comContra Guys: As seniors’ population rises, Extendicare worth a lookApril 8, 2024 | finance.yahoo.comCan Extendicare Inc. (TSE:EXE) Maintain Its Strong Returns?April 4, 2024 | theglobeandmail.comExtendicare Announces Timing of 2024 First Quarter Results and Conference CallApril 4, 2024 | finance.yahoo.comExtendicare Announces Timing of 2024 First Quarter Results and Conference CallMarch 20, 2024 | fool.caInvest $374.50 Each Month to Create Passive Income of $288 in 2024March 10, 2024 | seekingalpha.comExtendicare Inc. (EXETF) Q4 2023 Earnings Call TranscriptSee More Headlines Receive EXE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 8/15 Dividend7/31/2024Last Earnings8/12/2024Dividend Payable8/15/2024Ex-Dividend for 9/16 Dividend8/30/2024Today9/07/2024Dividend Payable9/16/2024Next Earnings (Estimated)11/14/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Medical Care Facilities Sub-IndustryN/A Current SymbolTSE:EXE CUSIPN/A CIKN/A Webwww.extendicare.com Phone905-470-4000FaxN/AEmployees23,000Year FoundedN/APrice Target and Rating Average Stock Price TargetC$9.17 High Stock Price TargetC$9.50 Low Stock Price TargetC$8.50 Potential Upside/Downside+3.7%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)C$0.68 Trailing P/E Ratio13.00 Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$59.44 million Net Margins4.28% Pretax MarginN/A Return on Equity60.00% Return on Assets7.16% Debt Debt-to-Equity Ratio305.80 Current Ratio0.60 Quick Ratio0.98 Sales & Book Value Annual SalesC$1.39 billion Price / Sales0.53 Cash FlowC$2.76 per share Price / Cash Flow3.20 Book ValueC$1.28 per share Price / Book6.91Miscellaneous Outstanding Shares83,470,000Free FloatN/AMarket CapC$737.87 million OptionableNot Optionable Beta1.26 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesDr. Michael R. Guerriere M.D. (Age 59)MBA, CEO, President & Director Comp: $1.21MMr. David E. BaconSenior VP & CFOJoe BelinskyVP of Information Technology & Chief Information OfficerMs. Jillian E. FountainVice President of Investor RelationsMs. Kathryn Killoran BradleyVice President of Corporate DevelopmentMs. Katie LeMoyneSenior VP & Chief Human Resources OfficerMs. Wendy GilmourSenior Vice President of Long-term Care OperationsMs. Amie Cathleen VahrmeyerVice President of Long-Term Care Operations for ONMore ExecutivesKey CompetitorsdentalcorpTSE:DNTLSienna Senior LivingTSE:SIAWELL Health TechnologiesTSE:WELLMedical FacilitiesTSE:DRKDA GroupCVE:KDAView All Competitors EXE Stock Analysis - Frequently Asked Questions How have EXE shares performed this year? Extendicare's stock was trading at C$7.28 at the beginning of the year. Since then, EXE stock has increased by 21.4% and is now trading at C$8.84. View the best growth stocks for 2024 here. How were Extendicare's earnings last quarter? Extendicare Inc. (TSE:EXE) announced its quarterly earnings data on Monday, August, 12th. The company reported $0.29 earnings per share for the quarter. The business had revenue of $348.48 million for the quarter, compared to analysts' expectations of $360.20 million. Extendicare had a net margin of 4.28% and a trailing twelve-month return on equity of 60.00%. How do I buy shares of Extendicare? Shares of EXE stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of Extendicare own? Based on aggregate information from My MarketBeat watchlists, some other companies that Extendicare investors own include Inter Pipeline (IPL), Pembina Pipeline (PPL), BCE (BCE), Chorus Aviation (CHR), Cenovus Energy (CVE), Medical Facilities (DR) and Martinrea International (MRE). This page (TSE:EXE) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Extendicare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Extendicare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
